Scarica l'app Stockscreener
8.79
2.33%
0.20
Dopo l'orario di chiusura:
8.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$8.59
Aprire:
$8.59
Volume 24 ore:
459.55K
Relative Volume:
0.50
Capitalizzazione di mercato:
$359.65M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-10.72
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
+2.09%
1M Prestazione:
-2.22%
6M Prestazione:
-40.29%
1 anno Prestazione:
-82.65%
Intervallo 1D:
$8.36
$8.81
Intervallo di 1 settimana:
$8.32
$8.87
Portata 52W:
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
8.79 | 351.47M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
Real time breakdown of RxSight Inc. stock performanceTreasury Yields & Fast Gaining Stock Reports - newser.com
Best data tools to analyze RxSight Inc. stockExit Point & AI Driven Stock Movement Reports - newser.com
Analyzing drawdowns of RxSight Inc. with statistical toolsWatch List & Community Verified Swing Trade Signals - newser.com
Building trade automation scripts for RxSight Inc.Watch List & Consistent Growth Equity Picks - newser.com
Combining price and volume data for RxSight Inc.July 2025 Technicals & Fast Moving Stock Watchlists - newser.com
Will RxSight Inc. stock benefit from commodity pricesBull Run & Low Drawdown Trading Techniques - newser.com
Why RxSight Inc. stock is favored by top institutionsTrade Risk Assessment & Smart Allocation Stock Tips - newser.com
Can you recover from losses in RxSight Inc.Portfolio Risk Report & High Return Trade Opportunity Guides - newser.com
Is RxSight Inc. stock a top momentum playJuly 2025 Levels & Risk Controlled Daily Plans - newser.com
RxSight (RXST) Expected to Announce Earnings on Thursday - MarketBeat
Does RxSight Inc. qualify in momentum factor screeningWeekly Gains Report & Weekly Market Pulse Alerts - newser.com
Will a bounce in RxSight Inc. offer an exit2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com
Is RxSight Inc. meeting your algorithmic filter criteriaGap Up & Safe Swing Trade Setups - newser.com
Tools to monitor RxSight Inc. recovery probabilityWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Is RxSight Inc. showing signs of accumulationTrade Signal Summary & Short-Term High Return Strategies - newser.com
Why RxSight Inc. stock remains undervaluedTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - ACCESS Newswire
Can RxSight Inc. stock resist sector downturnsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
How analysts rate RxSight Inc. stock todayMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - fcp.pa.gov.br
RxSight, Inc. (NASDAQ:RXST) Q2 2025 Earnings Call Transcript - MSN
How RxSight Inc. stock reacts to job market dataJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - fcp.pa.gov.br
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
14.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):